Гематология / лейкозы / лимфомы

When Cancer Treatment Consumes Life: Lymphoma Patients Reveal the Hidden Burden of Time Toxicity

When Cancer Treatment Consumes Life: Lymphoma Patients Reveal the Hidden Burden of Time Toxicity Bioengineer.org

Advancing HIV-Associated Lymphoma Care Through Multi-Institutional Collaboration

Advancing HIV-Associated Lymphoma Care Through Multi-Institutional Collaboration CancerNetwork

Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis

How to Navigate Ramantamig’s Low-Grade Toxicities in Multiple Myeloma

How Can Cooperative Groups Close Outcome Gaps in HIV-Associated Lymphoma?

Iberdomide Combination Doubles PFS vs SOC Therapy in R/R Multiple Myeloma

Stanford scientists turn a cancer driver into a kill switch

A Stanford-designed molecule turns a major lymphoma-promoting protein against cancer cells, activating their own self-destruct machinery instead of simply blocking tumor growth. In mice, the treatment completely eliminated aggressive human lymphoma tumors within 11 days, although much more testing is needed before it…

Considering Talquetamab and Emerging Bispecifics in R/R Multiple Myeloma

Hope and Patient Advocacy in Relapsed/Refractory Multiple Myeloma

Dr. Ajay Gopal on lymphoma innovation, clinical trials and leadership

Dr. Ajay Gopal on lymphoma innovation, clinical trials and leadership Fred Hutchinson Cancer Research Center

Selinexor-Based Quadruplet Targets Myeloma After T-Cell Redirecting Therapy

Expanding CAR T and Bispecific Antibody Research in HIV-Associated Lymphoma

Global Platform Trial Aims to Transform Treatment of Children With Relapsed B-Cell Lymphoma

Global Platform Trial Aims to Transform Treatment of Children With Relapsed B-Cell Lymphoma Bioengineer.org

Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference

Nicole Michmerhuizen Shares Insights Into NUP98-Rearranged Leukemia at AACR Special Conference Oncodaily

Making Outpatient Cellular Therapy Dosing the Default in Multiple Myeloma